Inventor · disambiguated record
Nobuaki Ito
Also filed as: ITO NOBUAKI
27 granted patents·19 pending applications·91 citations·filing 2005–2025
96Inventor score
Top patents by PatentIndex Score
46 records- 0197US7888362B2Piperazine-substituted benzothiophenes for treatment of mental disordersOTSUKA PHARMA CO LTD·Filed 2006·Granted Feb 15, 2011·22 cites·9 claims
- 0292US8349840B2Piperazine-substituted benzothiophenes for treatment of mental disordersOTSUKA PHARMA CO LTD·Filed 2010·Granted Jan 8, 2013·11 cites·6 claims
- 0390US8618109B2Piperazine-substituted benzothiophenes for treatment of mental disordersOTSUKA PHARMA CO LTD·Filed 2012·Granted Dec 31, 2013·8 cites·3 claims
- 0486US9480686B2Piperazine-substituted benzothiophenes for treatment of mental disordersOTSUKA PHARMA CO LTD·Filed 2015·Granted Nov 1, 2016·3 cites·4 claims
- 0586US2025361224A1Pyrimidine compoundOTSUKA PHARMA CO LTD·Filed 2025·Application pending·0 cites
- 0685US9839637B1Piperazine-substituted benzothiophenes for treatment of mental disordersOTSUKA PHARMA CO LTD·Filed 2017·Granted Dec 12, 2017·2 cites·18 claims
- 0784US9206167B2Piperazine-substituted benzothiophenes for treatment of mental disordersOTSUKA PHARMA CO LTD·Filed 2013·Granted Dec 8, 2015·3 cites·4 claims
- 0884US8071600B2Derivatives of 4-piperazin-1-yl-4-benzo[B]thiophene suitable for the treatment of CNS disordersYAMASHITA HIROSHI·Filed 2006·Granted Dec 6, 2011·7 cites·14 claims
- 0982US10000450B2N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitorsOTSUKA PHARMA CO LTD·Filed 2017·Granted Jun 19, 2018·3 cites·6 claims
- 1082US9499525B2Dihydrate of benzothiophene compound or of a salt thereof, and process for producing the sameOTSUKA PHARMA CO LTD·Filed 2013·Granted Nov 22, 2016·5 cites·12 claims
- 1179US8084442B2N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitorsKURIMURA MUNEAKI·Filed 2006·Granted Dec 27, 2011·4 cites·9 claims
- 1278US10800758B2Pyrimidine compoundOTSUKA PHARMA CO LTD·Filed 2018·Granted Oct 13, 2020·1 cites·88 claims
- 1378US8815871B2N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitorsOTSUKA PHARMA CO LTD·Filed 2013·Granted Aug 26, 2014·3 cites·6 claims
- 1478US8420623B2N, N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitorsKURIMURA MUNEAKI·Filed 2011·Granted Apr 16, 2013·4 cites·10 claims
- 1577US10603331B2Method of treating disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamineOTSUKA PHARMA CO LTD·Filed 2018·Granted Mar 31, 2020·1 cites·5 claims
- 1677US2023138411A1Pyrimidine compoundOTSUKA PHARMA CO LTD·Filed 2022·Application pending·0 cites
- 1777US2021113556A1Piperazine-Substituted Benzothiophenes For Treatment of Mental DisordersOTSUKA PHARMA CO LTD·Filed 2020·Application pending·0 cites
- 1876US8188277B2Aromatic compounds for suppressing the generation of collagenFUKUSHIMA TAE·Filed 2005·Granted May 29, 2012·6 cites·14 claims
- 1974US8598162B2Derivatives of 4-piperazin-1-yl-4-benzo[B]thiophene suitable for the treatment of CNS disordersYAMASHITA HIROSHI·Filed 2011·Granted Dec 3, 2013·2 cites·12 claims
- 2074US2020237755A1Piperazine-Substituted Benzothiophenes For Treatment of Mental DisordersOTSUKA PHARMA CO LTD·Filed 2020·Application pending·0 cites
- 2173US2019321359A1Piperazine-Substituted Benzothiophenes For Treatment of Mental DisordersOTSUKA PHARMA CO LTD·Filed 2019·Application pending·0 cites
- 2273US2023049327A1Dihydrate of benzothiophene compound or of a salt thereof, and process for producing the sameOTSUKA PHARMA CO LTD·Filed 2022·Application pending·0 cites
- 2372US10407415B2Dihydrate of benzothiophene compound or of a salt thereof, and process for producing the sameOTSUKA PHARMA CO LTD·Filed 2016·Granted Sep 10, 2019·1 cites·3 claims
- 2472US7834002B24-amino-5-cyanopyrimidine derivativesOTSUKA PHARMA CO LTD·Filed 2005·Granted Nov 16, 2010·2 cites·11 claims
- 2572US2019117648A1Piperazine-Substituted Benzothiophenes For Treatment of Mental DisordersOTSUKA PHARMA CO LTD·Filed 2018·Application pending·0 cites
- 2671US11273168B2Methods of treating anxiety by administering a substituted quinoloneOTSUKA PHARMA CO LTD·Filed 2020·Granted Mar 15, 2022·0 cites·6 claims
- 2770US7989446B24-amino 5-cyanopyrimidine derivativesOTSUKA PHARMA CO LTD·Filed 2010·Granted Aug 2, 2011·2 cites·5 claims
- 2869US2018214444A1Piperazine-Substituted Benzothiophenes For Treatment of Mental DisordersOTSUKA PHARMA CO LTD·Filed 2017·Application pending·0 cites
- 2968US7655680B2Thiazole compound and use thereofOTSUKA PHARMA CO LTD·Filed 2005·Granted Feb 2, 2010·1 cites·6 claims
- 3068US2025304558A1Heterocyclic compounds for the treatment of epilepsyOTSUKA PHARMA CO LTD·Filed 2025·Application pending·0 cites
- 3167US2020140424A1Dihydrate of benzothiophene compound or of a salt thereof, and process for producing the sameOTSUKA PHARMA CO LTD·Filed 2019·Application pending·0 cites
- 3267US2017231983A1Piperazine-Substituted Benzothiophenes For Treatment of Mental DisordersOTSUKA PHARMA CO LTD·Filed 2017·Application pending·0 cites
- 3367US2020399245A1Pyrimidine compoundOTSUKA PHARMA CO LTD·Filed 2020·Application pending·0 cites
- 3466USRE48059EPiperazine-substituted benzothiophenes for treatment of mental disordersOTSUKA PHARMA CO LTD·Filed 2006·Granted Jun 23, 2020·0 cites·15 claims
- 3566US2021115030A1Dihydrate of benzothiophene compound or of a salt thereof, and process for producing the sameOTSUKA PHARMA CO LTD·Filed 2020·Application pending·0 cites
- 3665US2017000786A1Piperazine-Substituted Benzothiophenes For Treatment of Mental DisordersOTSUKA PHARMA CO LTD·Filed 2016·Application pending·0 cites
- 3764US12391674B2Heterocyclic compounds for the treatment of epilepsyOTSUKA PHARMA CO LTD·Filed 2019·Granted Aug 19, 2025·0 cites·17 claims
- 3862US2018258038A1N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitorsOTSUKA PHARMA CO LTD·Filed 2018·Application pending·0 cites
- 3962US2024286999A1Azabicyclo[3.1.0]hexane compoundOTSUKA PHARMA CO LTD·Filed 2022·Application pending·0 cites
- 4060US10064879B2Method for treating depression and/or depression status with substituted quinoxaline compoundsOTSUKA PHARMA CO LTD·Filed 2017·Granted Sep 4, 2018·0 cites·7 claims
- 4160US9611214B2N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitorsKURIMURA MUNEAKI·Filed 2014·Granted Apr 4, 2017·0 cites·7 claims
- 4256US9090572B2Substituted quinoxalines compoundsITO NOBUAKI·Filed 2011·Granted Jul 28, 2015·0 cites·7 claims
- 4355US2014031334A1Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of cns disordersOTSUKA PHARMA CO LTD·Filed 2013·Application pending·0 cites
- 4454US2016058757A1Heterocyclic compounds for treating or preventing disorers caused by reduced neurotransmission of serotonin, norephnephrine or dopamineOTSUKA PHARMA CO LTD·Filed 2015·Application pending·0 cites
- 4552US8450352B2Thiazole compounds and their use for inhibiting phosphodiesterase 4, TNF-α, and IL-4TAKEMURA ISAO·Filed 2009·Granted May 28, 2013·0 cites·7 claims
- 4640US2012238750A1Aromatic compoundFUKUSHIMA TAE·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nobuaki Ito files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →